Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical silymarin for melasma
ACTRN12612000602820Phase 3Completed
- Sponsor
- D Tagreed Altaei
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of silymarin in melasma (3 arms), sponsored by D Tagreed Altaei. Primary endpoints: Response to treatment by size of lesions, Melasma Area and Severity Index and 1 more. Started Jun 2007; status: completed.
02
Drugs
silymarin
03
Conditions
melasma
Beyond the preview
Go deeper on ACTRN12612000602820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000602820.